Blue Fin Capital’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | – | Sell |
-5,700
| Closed | -$289K | – | 130 |
|
2017
Q3 | $289K | Sell |
5,700
-160
| -3% | -$8.11K | 0.18% | 111 |
|
2017
Q2 | $315K | Sell |
5,860
-624
| -10% | -$33.5K | 0.2% | 108 |
|
2017
Q1 | $342K | Sell |
6,484
-1,120
| -15% | -$59.1K | 0.21% | 103 |
|
2016
Q4 | $366K | Buy |
7,604
+244
| +3% | +$11.7K | 0.24% | 97 |
|
2016
Q3 | $397K | Buy |
7,360
+224
| +3% | +$12.1K | 0.32% | 84 |
|
2016
Q2 | $387K | Hold |
7,136
| – | – | 0.32% | 83 |
|
2016
Q1 | $362K | Sell |
7,136
-964
| -12% | -$48.9K | 0.31% | 83 |
|
2015
Q4 | $409K | Sell |
8,100
-120
| -1% | -$6.06K | 0.32% | 85 |
|
2015
Q3 | $395K | Sell |
8,220
-360
| -4% | -$17.3K | 0.31% | 85 |
|
2015
Q2 | $447K | Buy |
8,580
+1,540
| +22% | +$80.2K | 0.32% | 86 |
|
2015
Q1 | $406K | Hold |
7,040
| – | – | 0.29% | 93 |
|
2014
Q4 | $376K | Buy |
7,040
+476
| +7% | +$25.4K | 0.28% | 90 |
|
2014
Q3 | $377K | Buy |
6,564
+172
| +3% | +$9.88K | 0.3% | 89 |
|
2014
Q2 | $427K | Hold |
6,392
| – | – | 0.34% | 84 |
|
2014
Q1 | $427K | Sell |
6,392
-60
| -0.9% | -$4.01K | 0.38% | 78 |
|
2013
Q4 | $431K | Buy |
+6,452
| New | +$431K | 0.38% | 78 |
|